PuSH - Publication Server of Helmholtz Zentrum München: Absence of CD4(+) and CD8(+) T cell expansion after primary multimodal treatment predicts early progression in inoperable stage III NSCLC.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Hofer, T.P. ; Nieto, A.* ; Kaesmann, L.* ; Taugner, J.* ; Pelikan, C. ; Katanov, D.* ; Eze, C.* ; Guggenberger, J.* ; Belka, C.* ; Nößner, E. ; Manapov, F.*

Absence of CD4(+) and CD8(+) T cell expansion after primary multimodal treatment predicts early progression in inoperable stage III NSCLC.

J. Clin. Oncol. 40:e20590 (2022)

Publ. Version/Full Text

	Free by publisher

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 0732-183X

e-ISSN 1527-7755

Journal Journal of Clinical Oncology - JCO

Quellenangaben Volume: 40, Issue: 16, Article Number: e20590

Publisher American Society of Clinical Oncology

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) CF Immunoanalytics (IMA)